All-cause mortality increased in 2020 to 2021 nationwide, with a slower increase in Medicaid expansion states, according to a study.

Individuals with achalasia show a higher risk for mortality than matched reference individuals from the general population, ...

The risk of both all-cause deaths and those caused by cardiovascular conditions in OSA patients is significantly reduced with the use of CPAP therapy.

A 2-item food security instrument captures similar mortality risk information as instruments with more items among adults in the US.

The following is a summary of “Comparison of all-cause mortality with different blood glucose control strategies in patients ...

South Korea: New data on 5α-reductase inhibitors (5-ARIs) reveals that low cumulative doses are associated with an increased ...

Adherence to American Cancer Society (ACS) nutrition and activity guidelines for cancer survivors is associated with lower ...

In mechanically ventilated patients with ARDS, the treatment effect of neuromuscular blockade on mortality likely varies with respiratory elastance.

High cardiovascular health was associated with a reduced effect of insulin resistance on all-cause and cardiovascular mortality risk.

A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.

Combination therapy with GLP-1 RAs and thiazolidinediones is associated with a reduced risk for mortality in patients with T2D, a study finds.

This research is important because many people experienced employment disruptions during the pandemic, which, in addition to loss of household income, also led to loss of employment-based health ...